RadNet’s DeepHealth strikes $103m deal to acquire iCAD
RadNet company DeepHealth has signed a $103m deal to acquire iCAD, an AI-powered breast cancer screening company based in New …
Post
-
-
Da Vinci and Hugo among 11 robotic systems recommended for NHS use
Surgeons on England’s National Health Service (NHS) will be able to use state-of-the-art robotic systems that will improve the care …
-
Podcast: retiring the one-size-fits-all care model for pressure injuries
Research estimates that pressure injuries (otherwise known as bedsores) are attributable to approximately 60,000 deaths per year in the US. …
-
Bruker to invest in German company RECIPE
Bruker has announced a significant investment in Germany-based company RECIPE Chemicals + Instruments, which provides mass spectrometry-based diagnostic assay kits. The …
-
Top NIH nutritionist retires, citing ‘censorship’ under RFK Jr’s leadership
A top nutritionist at the US National Institutes of Health (NIH) has elected to retire from his post, citing “censorship” …
-
Pearsanta to begin study of endometriosis test with IRB approval
Aditxt subsidiary Pearsanta has secured approval from WCG Clinical’s Institutional Review Board (IRB) to begin a clinical trial of the …
-
GeneDx to enhance genomic medicine offerings with Fabric Genomics acquisition
GeneDx has announced its intention to acquire Fabric Genomics, which allows it to advance in the field of genomic medicine …
-
Abbott US diabetes device sales up 27% amid largely positive Q1
Abbott has posted strong revenue for its diabetes devices in Q1, despite overall sales for the company narrowly missing Wall …
-
LUMA Vision nets FDA clearance for 4D imaging catheter
The US Food and Drug Administration (FDA) has cleared LUMA Vision’s Verafeye catheter-based imaging system. Verafeye is a four-dimensional (4D), ultrasound-based …
-
Health Canada approves NanoSpeed’s test for vitamin D detection
Health Canada has granted approval for NanoSpeed Diagnostics’ Test4D Serum, designed to identify vitamin D levels in blood serum. This development …
-
FDA clears eGenesis’ genetically engineered porcine liver for Phase I trial
eGenesis has gained US Food and Drug Administration (FDA) clearance on an investigational new drug (IND) application for a genetically …
-
APAC coronary stent market set to grow at 3.2% CAGR through 2034
The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery disease (CAD) …
-
FDA authorises ActiveProtective’s belt for fall-related hip injuries
The US Food and Drug Administration (FDA) has granted marketing authorisation for ActiveProtective Technologies’ (APT) Tango Belt, a prescription-only wearable …
-
Cadwell invests in Australian company Seer Medical
Cadwell Industries has made a strategic investment in Australia-based Seer Medical, which specialises in home-based epilepsy diagnostics. The investment, made in …
-
FDA conditionally approves second cohort of Carmat’s artificial heart study
French company Carmat has secured conditional approval from the US Food and Drug Administration (FDA) to initiate the second cohort …
